Literature DB >> 9777406

Functional roles of the lung surfactant proteins SP-A and SP-D in innate immunity.

K B Reid1.   

Abstract

The surfactant proteins SP-A and SP-D are known to play important roles in innate immunity in the lungs in the protection against a wide variety of potential pathogens, which include viruses, bacteria and fungi. Recognition of the pathogens is, in most cases, mediated by the Ca+2-dependent binding of the C-type lectin domains of SP-A, or SP-D, to carbohydrate structures on the surface of the microorganisms. This can cause agglutination of the pathogens and also possibly their enhanced killing and clearance by phagocytic cells which carry receptors for SP-A or SP-D. Both SP-A and SP-D are found in a number of other sites in the body, in various secretions, and therefore may play a wider protective role than was initially envisaged.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9777406     DOI: 10.1016/S0171-2985(98)80027-2

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  11 in total

1.  Surfactant protein A is defective in abrogating inflammation in asthma.

Authors:  Ying Wang; Dennis R Voelker; Njira L Lugogo; Guirong Wang; Joanna Floros; Jennifer L Ingram; Hong Wei Chu; Tony D Church; Pitchaimani Kandasamy; Daniel Fertel; Jo Rae Wright; Monica Kraft
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-22       Impact factor: 5.464

Review 2.  Structure, genetics and function of the pulmonary associated surfactant proteins A and D: The extra-pulmonary role of these C type lectins.

Authors:  Frederico Vieira; Johannes W Kung; Faizah Bhatti
Journal:  Ann Anat       Date:  2017-03-27       Impact factor: 2.698

3.  Alveolar surfactant protein D content modulates bleomycin-induced lung injury.

Authors:  John Casey; Jennifer Kaplan; Elena N Atochina-Vasserman; Andrew J Gow; Helchem Kadire; Yaniv Tomer; James H Fisher; Samuel Hawgood; Rashmin C Savani; Michael F Beers
Journal:  Am J Respir Crit Care Med       Date:  2005-06-30       Impact factor: 21.405

4.  Size influences the effect of hydrophobic nanoparticles on lung surfactant model systems.

Authors:  Mridula V Dwivedi; Rakesh Kumar Harishchandra; Olga Koshkina; Michael Maskos; Hans-Joachim Galla
Journal:  Biophys J       Date:  2014-01-07       Impact factor: 4.033

5.  Lung effector memory and activated CD4+ T cells display enhanced proliferation in surfactant protein A-deficient mice during allergen-mediated inflammation.

Authors:  Amy M Pastva; Sambuddho Mukherjee; Charles Giamberardino; Bethany Hsia; Bernice Lo; Gregory D Sempowski; Jo Rae Wright
Journal:  J Immunol       Date:  2011-01-21       Impact factor: 5.422

6.  Surfactant protein D enhances phagocytosis and killing of unencapsulated phase variants of Klebsiella pneumoniae.

Authors:  I Ofek; A Mesika; M Kalina; Y Keisari; R Podschun; H Sahly; D Chang; D McGregor; E Crouch
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

7.  Interaction of surfactant protein A with lipopolysaccharide and regulation of inflammatory cytokines in the THP-1 monocytic cell line.

Authors:  M Song; D S Phelps
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

8.  Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activities.

Authors:  Lyndsay M Schaeffer; Francis X McCormack; Huixing Wu; Alison A Weiss
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

9.  Nanoparticle interaction with model lung surfactant monolayers.

Authors:  Rakesh Kumar Harishchandra; Mohammed Saleem; Hans-Joachim Galla
Journal:  J R Soc Interface       Date:  2009-10-21       Impact factor: 4.118

10.  Pre-exposure to mechanical ventilation and endotoxemia increases Pseudomonas aeruginosa growth in lung tissue during experimental porcine pneumonia.

Authors:  Jesper Sperber; Axel Nyberg; Anders Krifors; Paul Skorup; Miklós Lipcsey; Markus Castegren
Journal:  PLoS One       Date:  2020-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.